Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structural Basis for Reversible and Irreversible Inhibition of Human Cathepsin L by their Respective dipeptidyl glyoxal and diazomethylketone Inhibitors

Journal Article · · Journal of Structural Biology

Cathepsin L plays a key role in many pathophysiological conditions including rheumatoid arthritis, tumor invasion and metastasis, bone resorption and remodeling. Here we report the crystal structures of two analogous dipeptidyl inhibitor complexes which inhibit human cathepsin L in reversible and irreversible modes, respectively. To-date, there are no crystal structure reports of complexes of proteases with their glyoxal inhibitors or complexes of cathepsin L and their diazomethylketone inhibitors. These two inhibitors - inhibitor 1, an {alpha}-keto-{beta}-aldehyde and inhibitor 2, a diazomethylketone, have different groups in the S1 subsite. Inhibitor 1 [Z-Phe-Tyr (OBut)-COCHO], with a Ki of 0.6 nM, is the most potent, reversible, synthetic peptidyl inhibitor of cathepsin L reported to-date. The structure of the inhibitor 1 complex was refined up to 2.2 {angstrom} resolution. The structure of the complex of the inhibitor 2 [Z-Phe-Tyr (t-Bu)-diazomethylketone], an irreversible inhibitor that can inactivate cathepsin L at {micro}M concentrations, was refined up to 1.76 {angstrom} resolution. These two inhibitors have substrate-like interactions with the active site cysteine (Cys25). Inhibitor 1 forms a tetrahedral hemithioacetal adduct, whereas the inhibitor 2 forms a thioester with Cys25. The inhibitor 1 {beta}-aldehyde group is shown to make a hydrogen bond with catalytic His163, whereas the ketone carbonyl oxygen of the inhibitor 2 interacts with the oxyanion hole. tert-Butyl groups of both inhibitors are found to make several non-polar contacts with S' subsite residues of cathepsin L. These studies, combined with other complex structures of cathepsin L, reveal the structural basis for their potency and selectivity.

Research Organization:
BROOKHAVEN NATIONAL LABORATORY (BNL)
Sponsoring Organization:
USDOE SC OFFICE OF SCIENCE (SC)
DOE Contract Number:
AC02-98CH10886
OSTI ID:
1042033
Report Number(s):
BNL--97711-2012-JA
Journal Information:
Journal of Structural Biology, Journal Name: Journal of Structural Biology Journal Issue: 1 Vol. 173; ISSN JSBIEM; ISSN 1047-8477
Country of Publication:
United States
Language:
English

Similar Records

Exploring Inhibitor Binding at the S Subsites of Cathepsin L
Journal Article · Mon Dec 31 23:00:00 EST 2007 · Journal of Medicinal Chemistry · OSTI ID:959535

Exploration of the primary specificity site of cathepsin B
Journal Article · Thu Apr 14 23:00:00 EST 1983 · Arch. Biochem. Biophys.; (United States) · OSTI ID:5013844

Comparison of the behavior of chymotrypsin and cathepsin B towards peptidyl diazomethyl ketones
Journal Article · Tue Aug 28 00:00:00 EDT 1979 · Biochem. Biophys. Res. Commun.; (United States) · OSTI ID:5064189